News

Filter

Current filters:

GenericsPfizer

1 to 9 of 120 results

Hospira fourth-qtr 2014 earnings beat expectations

Hospira fourth-qtr 2014 earnings beat expectations

12-02-2015

US drugmaker Hospira, a leading provider of injectable drugs and infusion technologies, and a global…

FinancialGenericsHospiraPfizerUnited States

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

Teva, Actavis and Mylan launch generic Celebrex capsules in USA

10-12-2014

Israel-based generics giant Teva Pharmaceutical Industries said today that it has launched the first…

ActavisAnti-Arthritics/RheumaticsCelebrexGenericsMarkets & MarketingMylanPfizerTeva Pharmaceutcal IndustriesUSA

FDA revokes tentative approval of Ranbaxy’s generic Nexium and Valcyte

07-11-2014

Indian generics drugmaker Ranbaxy Laboratories revealed in a Bombay Stock Exchange filing that it has…

Anti-viralsAstraZenecaGastro-intestinalsGenericsNexiumPfizerRanbaxy LaboratoriesRegulationSun PharmaceuticalUSAValcyte

Pfizer prevails in Sutent patent dispute

Pfizer prevails in Sutent patent dispute

23-10-2014

The US District Court for the District of Delaware has upheld US pharma giant Pfizer’s basic patent…

GenericsLegalMylanOncologyPatentsPfizerSutentUSA

Actavis challenges Quillivant XR patent

16-10-2014

Ireland-headquartered generics major Actavis confirmed that it has filed an Abbreviated New Drug Application…

ActavisGenericsLegalNeurologicalPatentsPfizerQuillivantRegulationTris PharmaUSA

Pfizer to acquire generics firm InnoPharma for up to $360 million

Pfizer to acquire generics firm InnoPharma for up to $360 million

17-07-2014

Having failed (so far) in its mega billion dollar ($116 billion) attempt to buy Anglo-Swedish drug major…

GenericsInnoPharmaMergers & AcquisitionsOncologyOphthalmicsPfizer

South Africa regulator gives MSF access to cheaper TB drug linezolid

South Africa regulator gives MSF access to cheaper TB drug linezolid

01-07-2014

After a three-year long struggle, humanitarian aid agency Medecins Sans Frontieres has received approval…

Antibiotics and Infectious diseasesGenericsHealthcareLinezolidPfizerRegulationSouth AfricaZyvox

1 to 9 of 120 results

COMPANY SPOTLIGHT

Menarini

Back to top